Objective: To evaluate long-term response of cats with stomatitis to tooth extraction.
Design: Retrospective case series.
Animals: 95 cats with stomatitis.
This study assessed proof-of-concept for use of polyamine inhibitor 2-diluoromethylornithine (DFMO) as a treatment for oral squamous cell carcinoma (SCC) in client-owned cats. Polyamine levels in tumor tissue and normal oral mucosa were quantified before and after treatment. DFMO was administered orally to 14 client-owned cats with histologically confirmed oral SCC.
View Article and Find Full Text PDF